Trait | Trait definition and ascertainment | Unit | Ancestral inclusion | Total N (cases N) | Study and data source |
---|---|---|---|---|---|
Height | Measured or self-reported | Per SD (cm) | 76% EUR, 9% EAS, 8% HIS, 5% AFR, 1% SAS | 5,380,080 | |
ANP | Relative aptamer abundance in plasma | Per SD (RFU) | 100% EUR | 35,559 | |
BNP | |||||
NT-pro-BNP | Plasma Olink proximity extension assay | Per SD (NPX) | 100% EUR | 21,758 | |
CAD | ACS, CAD, or MI. Medical recordsa or self-report | Case statusb | ~ 85% EUR, 15% EAS | 1,378,170 (210,842) | |
Stroke | All-cause. Medical records or self-report | Case statusb | 67% EUR, 25% EAS, 4% AFR, 3% SAS, 1% HIS | 1,614,080 (110,182) | |
HF | Medical records. Study-based adjudicated self-report | Case statusb | > 99% EUR | 977,323 (47,309) | |
T2DM | Study-based diagnosis, medical records, or self-report | Case statusb | 51% EUR, 28% EAS, 8% SAS, 7% AFR, 6% HIS | 1,339,889 (180,834) | |
CKD | Study-based, eGFR < 60 mL/min/1.73m2 | Case statusb | ~ 77% EUR | 625,219 (64,164) | |
LDL-C | Fasting or non-fasting. Adjusted for medication: LDL-C ÷ 0.7, TG ÷ 0.8 | Per SD (mg/dL) | 80% EUR, 9% EAS, 6% AFR, 3% HIS, 2% SAS | 1,654,960 | |
HDL-C | |||||
TG | |||||
SBP | Mean of two seated measures taken a few moments apart | Per SD (mmHg) | 100% EUR | 317,756 | |
DBP | 317,756 |